Annual CFF
$38.16 M
+$138.52 M+138.02%
31 March 2024
Summary:
Haemonetics annual cash flow from financing activities is currently $38.16 million, with the most recent change of +$138.52 million (+138.02%) on 31 March 2024. During the last 3 years, it has fallen by -$329.30 million (-89.62%). HAE annual CFF is now -91.74% below its all-time high of $461.85 million, reached on 30 March 2013.HAE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$74.80 M
-$408.50 M-122.42%
28 September 2024
Summary:
Haemonetics quarterly cash flow from financing activities is currently -$74.80 million, with the most recent change of -$408.50 million (-122.42%) on 28 September 2024. Over the past year, it has dropped by -$67.63 million (-943.00%). HAE quarterly CFF is now -115.63% below its all-time high of $478.58 million, reached on 29 September 2012.HAE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$304.81 M
-$67.63 M-18.16%
28 September 2024
Summary:
Haemonetics TTM cash flow from financing activities is currently $304.81 million, with the most recent change of -$67.63 million (-18.16%) on 28 September 2024. Over the past year, it has increased by +$363.87 million (+616.17%). HAE TTM CFF is now -39.77% below its all-time high of $506.10 million, reached on 29 September 2012.HAE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HAE Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +138.0% | -943.0% | +616.2% |
| 3 y3 years | -89.6% | -3575.9% | -28.4% |
| 5 y5 years | +175.4% | +33.5% | +284.0% |
HAE Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -89.6% | +138.0% | -122.4% | at low | -28.4% | +383.5% |
| 5 y | 5 years | -89.6% | +129.1% | -117.3% | +50.1% | -28.4% | +284.0% |
| alltime | all time | -91.7% | +129.1% | -115.6% | +50.1% | -39.8% | +279.0% |
Haemonetics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$74.80 M(-122.4%) | $304.81 M(-18.2%) |
| June 2024 | - | $333.69 M(-625.5%) | $372.45 M(+876.1%) |
| Mar 2024 | $38.16 M(-138.0%) | - | - |
| Mar 2024 | - | -$63.50 M(-158.0%) | $38.16 M(-61.9%) |
| Dec 2023 | - | $109.43 M(-1625.8%) | $100.06 M(-269.4%) |
| Sept 2023 | - | -$7.17 M(+1099.3%) | -$59.05 M(-23.9%) |
| June 2023 | - | -$598.00 K(-62.7%) | -$77.57 M(-22.7%) |
| Mar 2023 | -$100.36 M(+537.3%) | -$1.60 M(-96.8%) | -$100.36 M(-6.7%) |
| Dec 2022 | - | -$49.68 M(+93.4%) | -$107.53 M(+79.6%) |
| Sept 2022 | - | -$25.69 M(+9.8%) | -$59.88 M(+59.6%) |
| June 2022 | - | -$23.39 M(+166.9%) | -$37.51 M(+138.2%) |
| Mar 2022 | -$15.75 M(-104.3%) | -$8.77 M(+330.7%) | -$15.75 M(-103.7%) |
| Dec 2021 | - | -$2.04 M(-38.6%) | $425.77 M(+53.2%) |
| Sept 2021 | - | -$3.31 M(+102.9%) | $277.87 M(+28.1%) |
| June 2021 | - | -$1.63 M(-100.4%) | $216.87 M(-41.0%) |
| Mar 2021 | $367.45 M(-380.1%) | $432.76 M(-388.6%) | $367.45 M(-781.3%) |
| Dec 2020 | - | -$149.94 M(+133.1%) | -$53.94 M(-208.2%) |
| Sept 2020 | - | -$64.32 M(-143.2%) | $49.85 M(+2915.8%) |
| June 2020 | - | $148.95 M(+1209.8%) | $1.65 M(-101.3%) |
| Mar 2020 | -$131.21 M(+159.2%) | $11.37 M(-124.6%) | -$131.21 M(-3.2%) |
| Dec 2019 | - | -$46.15 M(-59.0%) | -$135.59 M(-18.1%) |
| Sept 2019 | - | -$112.52 M(-799.3%) | -$165.64 M(+211.3%) |
| June 2019 | - | $16.09 M(+130.0%) | -$53.20 M(+5.1%) |
| Mar 2019 | -$50.63 M(-58.0%) | $7.00 M(-109.2%) | -$50.63 M(-70.3%) |
| Dec 2018 | - | -$76.21 M(>+9900.0%) | -$170.28 M(+98.5%) |
| Sept 2018 | - | -$79.00 K(-100.4%) | -$85.76 M(-12.9%) |
| June 2018 | - | $18.66 M(-116.6%) | -$98.43 M(-18.4%) |
| Mar 2018 | -$120.64 M(+99.7%) | -$112.65 M(-1456.3%) | -$120.64 M(+554.3%) |
| Dec 2017 | - | $8.31 M(-165.2%) | -$18.44 M(-74.4%) |
| Sept 2017 | - | -$12.75 M(+259.2%) | -$72.13 M(+22.3%) |
| June 2017 | - | -$3.55 M(-66.0%) | -$58.98 M(-2.4%) |
| Mar 2017 | -$60.41 M(-3.5%) | -$10.45 M(-77.0%) | -$60.41 M(-7.9%) |
| Dec 2016 | - | -$45.39 M(<-9900.0%) | -$65.62 M(+182.6%) |
| Sept 2016 | - | $411.00 K(-108.2%) | -$23.22 M(-38.6%) |
| June 2016 | - | -$4.99 M(-68.1%) | -$37.84 M(-39.6%) |
| Mar 2016 | -$62.62 M(+88.9%) | -$15.65 M(+423.5%) | -$62.62 M(+40.9%) |
| Dec 2015 | - | -$2.99 M(-79.0%) | -$44.45 M(+6.6%) |
| Sept 2015 | - | -$14.21 M(-52.3%) | -$41.69 M(+22.2%) |
| June 2015 | - | -$29.77 M(-1282.4%) | -$34.12 M(+2.9%) |
| Mar 2015 | -$33.16 M(+60.2%) | $2.52 M(-1234.2%) | -$33.16 M(-20.5%) |
| Dec 2014 | - | -$222.00 K(-96.7%) | -$41.71 M(-20.2%) |
| Sept 2014 | - | -$6.64 M(-76.9%) | -$52.29 M(-11.4%) |
| June 2014 | - | -$28.81 M(+377.7%) | -$59.01 M(+185.1%) |
| Mar 2014 | -$20.70 M(-104.5%) | -$6.03 M(-44.2%) | -$20.70 M(-52.8%) |
| Dec 2013 | - | -$10.80 M(-19.2%) | -$43.85 M(+19.1%) |
| Sept 2013 | - | -$13.37 M(-240.7%) | -$36.83 M(-108.1%) |
| June 2013 | - | $9.50 M(-132.6%) | $455.13 M(-1.5%) |
| Mar 2013 | $461.85 M(-1615.8%) | -$29.18 M(+673.3%) | $461.85 M(-6.9%) |
| Dec 2012 | - | -$3.77 M(-100.8%) | $496.28 M(-1.9%) |
| Sept 2012 | - | $478.58 M(+2849.3%) | $506.10 M(-2804.9%) |
| June 2012 | - | $16.23 M(+209.4%) | -$18.71 M(-38.6%) |
| Mar 2012 | -$30.47 M(+68.5%) | $5.24 M(-13.2%) | -$30.47 M(-3.7%) |
| Dec 2011 | - | $6.04 M(-113.1%) | -$31.63 M(+152.3%) |
| Sept 2011 | - | -$46.22 M(-1134.7%) | -$12.54 M(-130.3%) |
| June 2011 | - | $4.47 M(+9.3%) | $41.32 M(-328.5%) |
| Mar 2011 | -$18.08 M(+29.4%) | $4.09 M(-83.7%) | -$18.08 M(+4.3%) |
| Dec 2010 | - | $25.13 M(+229.1%) | -$17.34 M(-76.3%) |
| Sept 2010 | - | $7.64 M(-113.9%) | -$73.18 M(-16.6%) |
| June 2010 | - | -$54.94 M(-1236.7%) | -$87.75 M(+528.1%) |
| Mar 2010 | -$13.97 M(-54.5%) | $4.83 M(-115.7%) | -$13.97 M(-10.8%) |
| Dec 2009 | - | -$30.71 M(+342.7%) | -$15.66 M(-204.4%) |
| Sept 2009 | - | -$6.94 M(-136.8%) | $14.99 M(+483.0%) |
| June 2009 | - | $18.84 M(+499.6%) | $2.57 M(-108.4%) |
| Mar 2009 | -$30.74 M(-58.0%) | $3.14 M(-5814.5%) | -$30.74 M(-8.8%) |
| Dec 2008 | - | -$55.00 K(-99.7%) | -$33.69 M(-12.4%) |
| Sept 2008 | - | -$19.36 M(+33.8%) | -$38.47 M(-44.4%) |
| June 2008 | - | -$14.46 M(-7673.3%) | -$69.22 M(-5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | -$73.23 M(+106.0%) | $191.00 K(-104.0%) | -$73.23 M(+0.8%) |
| Dec 2007 | - | -$4.83 M(-90.4%) | -$72.64 M(-27.3%) |
| Sept 2007 | - | -$50.11 M(+171.2%) | -$99.98 M(+83.4%) |
| June 2007 | - | -$18.48 M(-2483.9%) | -$54.51 M(+53.3%) |
| Mar 2007 | -$35.55 M(-394.0%) | $775.00 K(-102.4%) | -$35.55 M(+16.1%) |
| Dec 2006 | - | -$32.16 M(+593.2%) | -$30.61 M(+1469.1%) |
| Sept 2006 | - | -$4.64 M(-1074.8%) | -$1.95 M(-125.5%) |
| June 2006 | - | $476.00 K(-91.7%) | $7.64 M(-36.8%) |
| Mar 2006 | $12.09 M(-16.8%) | $5.72 M(-263.2%) | $12.09 M(+5.3%) |
| Dec 2005 | - | -$3.50 M(-170.7%) | $11.48 M(-43.8%) |
| Sept 2005 | - | $4.95 M(+0.5%) | $20.42 M(+17.1%) |
| June 2005 | - | $4.93 M(-3.5%) | $17.44 M(+20.0%) |
| Mar 2005 | $14.53 M(+1923.8%) | $5.11 M(-6.0%) | $14.53 M(+284.3%) |
| Dec 2004 | - | $5.43 M(+175.6%) | $3.78 M(-27.2%) |
| Sept 2004 | - | $1.97 M(-2.5%) | $5.19 M(+67.8%) |
| June 2004 | - | $2.02 M(-135.8%) | $3.09 M(+330.9%) |
| Mar 2004 | $718.00 K(-101.5%) | -$5.64 M(-182.5%) | $718.00 K(-117.7%) |
| Dec 2003 | - | $6.84 M(-5489.0%) | -$4.05 M(-75.1%) |
| Sept 2003 | - | -$127.00 K(-64.2%) | -$16.28 M(-34.0%) |
| June 2003 | - | -$355.00 K(-96.6%) | -$24.65 M(-49.7%) |
| Mar 2003 | -$49.00 M(+424.9%) | -$10.41 M(+93.4%) | -$49.00 M(-30.6%) |
| Dec 2002 | - | -$5.38 M(-36.7%) | -$70.58 M(+9.8%) |
| Sept 2002 | - | -$8.50 M(-65.6%) | -$64.28 M(+39.9%) |
| June 2002 | - | -$24.70 M(-22.8%) | -$45.94 M(+392.1%) |
| Mar 2002 | -$9.34 M(-400.4%) | -$31.99 M(-3604.1%) | -$9.34 M(-131.3%) |
| Dec 2001 | - | $913.00 K(-90.7%) | $29.82 M(-29.5%) |
| Sept 2001 | - | $9.84 M(-17.3%) | $42.30 M(+57.2%) |
| June 2001 | - | $11.90 M(+66.1%) | $26.90 M(+765.4%) |
| Mar 2001 | $3.11 M(-117.5%) | $7.16 M(-46.5%) | $3.11 M(-127.2%) |
| Dec 2000 | - | $13.39 M(-341.0%) | -$11.45 M(-34.7%) |
| Sept 2000 | - | -$5.56 M(-53.3%) | -$17.53 M(-23.0%) |
| June 2000 | - | -$11.89 M(+60.9%) | -$22.78 M(+28.0%) |
| Mar 2000 | -$17.79 M(+223.1%) | -$7.39 M(-201.2%) | -$17.79 M(+11.8%) |
| Dec 1999 | - | $7.30 M(-167.6%) | -$15.90 M(-12.2%) |
| Sept 1999 | - | -$10.80 M(+56.5%) | -$18.11 M(+241.3%) |
| June 1999 | - | -$6.90 M(+25.3%) | -$5.30 M(-3.6%) |
| Mar 1999 | -$5.50 M(-113.7%) | -$5.50 M(-207.9%) | -$5.50 M(-788.1%) |
| Dec 1998 | - | $5.10 M(+155.0%) | $800.00 K(-114.0%) |
| Sept 1998 | - | $2.00 M(-128.2%) | -$5.70 M(-144.2%) |
| June 1998 | - | -$7.10 M(-987.5%) | $12.90 M(-67.8%) |
| Mar 1998 | $40.10 M(+1332.1%) | $800.00 K(-157.1%) | $40.10 M(+9.0%) |
| Dec 1997 | - | -$1.40 M(-106.8%) | $36.80 M(+1.4%) |
| Sept 1997 | - | $20.60 M(+2.5%) | $36.30 M(+87.1%) |
| June 1997 | - | $20.10 M(-904.0%) | $19.40 M(+592.9%) |
| Mar 1997 | $2.80 M(-114.7%) | -$2.50 M(+31.6%) | $2.80 M(-3.4%) |
| Dec 1996 | - | -$1.90 M(-151.4%) | $2.90 M(-149.2%) |
| Sept 1996 | - | $3.70 M(+5.7%) | -$5.90 M(-51.6%) |
| June 1996 | - | $3.50 M(-245.8%) | -$12.20 M(-35.8%) |
| Mar 1996 | -$19.00 M(-963.6%) | -$2.40 M(-77.6%) | -$19.00 M(-1.6%) |
| Dec 1995 | - | -$10.70 M(+311.5%) | -$19.30 M(+221.7%) |
| Sept 1995 | - | -$2.60 M(-21.2%) | -$6.00 M(-700.0%) |
| June 1995 | - | -$3.30 M(+22.2%) | $1.00 M(-54.5%) |
| Mar 1995 | $2.20 M(+22.2%) | -$2.70 M(-203.8%) | $2.20 M(-66.2%) |
| Dec 1994 | - | $2.60 M(-40.9%) | $6.50 M(+1200.0%) |
| Sept 1994 | - | $4.40 M(-309.5%) | $500.00 K(>+9900.0%) |
| June 1994 | - | -$2.10 M(-231.3%) | $0.00(-100.0%) |
| Mar 1994 | $1.80 M(-116.7%) | $1.60 M(-147.1%) | $1.80 M(-700.0%) |
| Dec 1993 | - | -$3.40 M(-187.2%) | -$300.00 K(<-9900.0%) |
| Sept 1993 | - | $3.90 M(-1400.0%) | $0.00(-100.0%) |
| June 1993 | - | -$300.00 K(-40.0%) | -$10.30 M(-4.6%) |
| Mar 1993 | -$10.80 M(-1450.0%) | -$500.00 K(-83.9%) | -$10.80 M(-18.8%) |
| Dec 1992 | - | -$3.10 M(-51.6%) | -$13.30 M(+160.8%) |
| Sept 1992 | - | -$6.40 M(+700.0%) | -$5.10 M(-304.0%) |
| June 1992 | - | -$800.00 K(-73.3%) | $2.50 M(+212.5%) |
| Mar 1992 | $800.00 K | -$3.00 M(-158.8%) | $800.00 K(-78.9%) |
| Dec 1991 | - | $5.10 M(+325.0%) | $3.80 M(-392.3%) |
| Sept 1991 | - | $1.20 M(-148.0%) | -$1.30 M(-48.0%) |
| June 1991 | - | -$2.50 M | -$2.50 M |
FAQ
- What is Haemonetics annual cash flow from financing activities?
- What is the all time high annual CFF for Haemonetics?
- What is Haemonetics annual CFF year-on-year change?
- What is Haemonetics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Haemonetics?
- What is Haemonetics quarterly CFF year-on-year change?
- What is Haemonetics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Haemonetics?
- What is Haemonetics TTM CFF year-on-year change?
What is Haemonetics annual cash flow from financing activities?
The current annual CFF of HAE is $38.16 M
What is the all time high annual CFF for Haemonetics?
Haemonetics all-time high annual cash flow from financing activities is $461.85 M
What is Haemonetics annual CFF year-on-year change?
Over the past year, HAE annual cash flow from financing activities has changed by +$138.52 M (+138.02%)
What is Haemonetics quarterly cash flow from financing activities?
The current quarterly CFF of HAE is -$74.80 M
What is the all time high quarterly CFF for Haemonetics?
Haemonetics all-time high quarterly cash flow from financing activities is $478.58 M
What is Haemonetics quarterly CFF year-on-year change?
Over the past year, HAE quarterly cash flow from financing activities has changed by -$67.63 M (-943.00%)
What is Haemonetics TTM cash flow from financing activities?
The current TTM CFF of HAE is $304.81 M
What is the all time high TTM CFF for Haemonetics?
Haemonetics all-time high TTM cash flow from financing activities is $506.10 M
What is Haemonetics TTM CFF year-on-year change?
Over the past year, HAE TTM cash flow from financing activities has changed by +$363.87 M (+616.17%)